Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38769544)

  • 1. Preparation and evaluation of fenbendazole methyl-β-cyclodextrin inclusion complexes.
    Ding Y; Zhang Z; Ding C; Xu S; Xu Z
    BMC Vet Res; 2024 May; 20(1):214. PubMed ID: 38769544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Use of Cyclodextrin Inclusion Complexes to Increase the Solubility and Pharmacokinetic Profile of Albendazole.
    Ding Y; Zhang Z; Ding C; Xu S; Xu Z
    Molecules; 2023 Oct; 28(21):. PubMed ID: 37959715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inclusion complex and nanoclusters of cyclodextrin to increase the solubility and efficacy of albendazole.
    Pacheco PA; Rodrigues LNC; Ferreira JFS; Gomes ACP; Veríssimo CJ; Louvandini H; Costa RLD; Katiki LM
    Parasitol Res; 2018 Mar; 117(3):705-712. PubMed ID: 29327323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promising applications in drug delivery systems of a novel β-cyclodextrin derivative obtained by green synthesis.
    García A; Leonardi D; Lamas MC
    Bioorg Med Chem Lett; 2016 Jan; 26(2):602-608. PubMed ID: 26642766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomly Methylated
    Ding Y; Xu S; Ding C; Zhang Z; Xu Z
    Molecules; 2024 Apr; 29(9):. PubMed ID: 38731409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of albendazole beta-cyclodextrin complexes.
    Castillo JA; Palomo-Canales J; Garcia JJ; Lastres JL; Bolas F; Torrado JJ
    Drug Dev Ind Pharm; 1999 Dec; 25(12):1241-8. PubMed ID: 10612019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preparation, characterization and antitumor of cyclodextrin inclusion of an anti-cancer drug regorafenib].
    Kai-Hang L; Mengying S; Guping T; Xiurong HU
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 46(2):144-152. PubMed ID: 28752706
    [No Abstract]   [Full Text] [Related]  

  • 8. Preparation, characterization and in vitro biological evaluation of (1:2) phenoxodiol-β-cyclodextrin complex.
    Yee EM; Hook JM; Bhadbhade MM; Vittorio O; Kuchel RP; Brandl MB; Tilley RD; Black DS; Kumar N
    Carbohydr Polym; 2017 Jun; 165():444-454. PubMed ID: 28363571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative plasma disposition of fenbendazole, oxfendazole and albendazole in dogs.
    Gokbulut C; Bilgili A; Hanedan B; McKellar QA
    Vet Parasitol; 2007 Sep; 148(3-4):279-87. PubMed ID: 17673370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid inclusion complexes of oleanolic acid with amino-appended β-cyclodextrins (ACDs): Preparation, characterization, water solubility and anticancer activity.
    Ren Y; Liu Y; Yang Z; Niu R; Gao K; Yang B; Liao X; Zhang J
    Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():68-76. PubMed ID: 27612690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inclusion complex of novel curcumin analogue CDF and β-cyclodextrin (1:2) and its enhanced in vivo anticancer activity against pancreatic cancer.
    Dandawate PR; Vyas A; Ahmad A; Banerjee S; Deshpande J; Swamy KV; Jamadar A; Dumhe-Klaire AC; Padhye S; Sarkar FH
    Pharm Res; 2012 Jul; 29(7):1775-86. PubMed ID: 22322899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and characterization of a new cyclodextrin derivative with improved properties to design oral dosage forms.
    García A; Priotti J; Codina AV; Vasconi MD; Quiroga AD; Hinrichsen LI; Leonardi D; Lamas MC
    Drug Deliv Transl Res; 2019 Feb; 9(1):273-283. PubMed ID: 30264285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and Biophysical Characterization of Quercetin Inclusion Complexes with β-Cyclodextrin Derivatives to be Formulated as Possible Nose-to-Brain Quercetin Delivery Systems.
    Manta K; Papakyriakopoulou P; Chountoulesi M; Diamantis DA; Spaneas D; Vakali V; Naziris N; Chatziathanasiadou MV; Andreadelis I; Moschovou K; Athanasiadou I; Dallas P; Rekkas DM; Demetzos C; Colombo G; Banella S; Javornik U; Plavec J; Mavromoustakos T; Tzakos AG; Valsami G
    Mol Pharm; 2020 Nov; 17(11):4241-4255. PubMed ID: 32986435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and evaluation of synthetic riluzole with β-cyclodextrin and 2,6-di-O-methyl-β-cyclodextrin inclusion complexes.
    Wang L; Li S; Tang P; Yan J; Xu K; Li H
    Carbohydr Polym; 2015 Sep; 129():9-16. PubMed ID: 26050882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, characteristic and pharmacological study on inclusion complex of sulfobutylether-β-cyclodextrin with glaucocalyxin A.
    Ren L; Jing J; Chen G; Miao Y; Wei P
    J Pharm Pharmacol; 2014 Jul; 66(7):927-34. PubMed ID: 24697809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and In Vitro Evaluation of the Complexes of Posaconazole with β- and 2,6-di-O-methyl-β-cyclodextrin.
    Tang P; Wang L; Ma X; Xu K; Xiong X; Liao X; Li H
    AAPS PharmSciTech; 2017 Jan; 18(1):104-114. PubMed ID: 26883260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of olanzapine and methyl-β-cyclodextrin complexes using a single-step, organic solvent-free supercritical fluid process: An approach to enhance the solubility and dissolution properties.
    Rudrangi SR; Trivedi V; Mitchell JC; Wicks SR; Alexander BD
    Int J Pharm; 2015 Oct; 494(1):408-16. PubMed ID: 26315120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of the oral praziquantel anthelmintic effect by cyclodextrin complexation.
    de Jesus MB; Pinto Lde M; Fraceto LF; Magalhães LA; Zanotti-Magalhães EM; de Paula E
    J Drug Target; 2010 Jan; 18(1):21-6. PubMed ID: 19624246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inclusion complex of GA-13316 with β-cyclodextrin: preparation, characterization, molecular modeling, and in vitro evaluation.
    Yang R; Chen JB; Xiao CF; Liu ZC; Gao ZY; Yan SJ; Zhang JH; Zhang HB; Lin J
    Carbohydr Polym; 2014 Oct; 111():655-62. PubMed ID: 25037400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid-state flurbiprofen and methyl-β-cyclodextrin inclusion complexes prepared using a single-step, organic solvent-free supercritical fluid process.
    Rudrangi SR; Kaialy W; Ghori MU; Trivedi V; Snowden MJ; Alexander BD
    Eur J Pharm Biopharm; 2016 Jul; 104():164-70. PubMed ID: 27163245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.